Management of hyperprolactinemia in psychiatric practice

by Dr Ovais Wadoo, Dr Yaasir Mamoojee and Dr Aadil Shah


Last reviewed: November 2019


Psychiatrists sometimes prescribe medication that is known to elevate prolactin levels.


Hyperprolactinemia can lead to adverse health outcomes and thus clinicians need not only be alert to the symptoms, but should be able to manage the consequences as well.


In this module we will:


  • discuss the physiology and regulation of prolactin


  • list the major physiological and pathological causes of hyperprolactinemia


  • identify the reasons for failure to recognise hyperprolactinemia


  • discuss the interpretation of blood results and the management of psychotropic-induced hyperprolactinemia.


Finally, we will include a flow diagram to assist clinicians in decision-making around the management of hyperprolactinemia.


Start the module


If you like this module, you may also be interested in:


Managing the adverse effects of clozapine by Dr James MacCabe and Dr Jennifer Brook


Safe lithium prescribing: initiation and monitoring by Dr Ekta Sharma, Dr Tayeem Pathan and Dr Stuart Adams


Psychotropic medication and the heart: Part 1 and Part 2 by Dr Sridevi Sira Mahalingappa, Professor Femi Oyebode and Dr Patrick O'Brien



BJPsych Advances: related articles for CPD Online



Related Advances articles


Download take-home notes to print and annotateDownload take-home notes to print and annotate

© 2022 Royal College of Psychiatrists